Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Nadine E Stephenson & Simon F Crowe. (2016) Statin Use, Ageing, and Cognition: A Review. Australian Psychologist 51:3, pages 188-205.
Read now
Read now
Ian Hamilton-Craig, David Colquhoun, Karam Kostner, Stan Woodhouse & Michael d’Emden. (2015) Lipid-modifying therapy in the elderly. Vascular Health and Risk Management 11, pages 251-263.
Read now
Read now
Chiara Pavanello & Giuliana Mombelli. (2015) Considering gender in prescribing statins: what do physicians need to know?. Clinical Lipidology 10:6, pages 499-512.
Read now
Read now
Articles from other publishers (23)
Fabrice Bonnet, Antoine Bénard, Pierre Poulizac, Mélanie Afonso, Aline Maillard, Francesco Salvo, Driss Berdaï, Nathalie Salles, Nicolas Rousselot, Sébastien Marchi, Nathalie Hayes & Jean-Philippe Joseph. (2020) Discontinuing statins or not in the elderly? Study protocol for a randomized controlled trial. Trials 21:1.
Crossref
Crossref
Giovanni ViscogliosiChiara DonfrancescoCinzia Lo NoceDiego VanuzzoFlavia CarleSimona GiampaoliLuigi Palmieri. (2020) Prevalence and Correlates of Statin Underuse for Secondary Prevention of Cardiovascular Disease in Older Adults 65–79 Years of Age: The Italian Health Examination Survey 2008–2012. Rejuvenation Research 23:5, pages 394-400.
Crossref
Crossref
Allyson M. Schweitzer, Molly A. Gingrich, Thomas J. Hawke & Irena A. Rebalka. (2020) The impact of statins on physical activity and exercise capacity: an overview of the evidence, mechanisms, and recommendations. European Journal of Applied Physiology 120:6, pages 1205-1225.
Crossref
Crossref
Zhen Zhou, Loai Albarqouni, Andrea J. Curtis, Monique Breslin & Mark Nelson. (2020) The Safety and Tolerability of Statin Therapy in Primary Prevention in Older Adults: A Systematic Review and Meta-analysis. Drugs & Aging 37:3, pages 175-185.
Crossref
Crossref
Xiaoming Jia, Mahmoud Al Rifai, Yochai Birnbaum, Sidney C. SmithJrJr & Salim S. Virani. (2019) The 2018 Cholesterol Management Guidelines: Topics in Secondary ASCVD Prevention Clinicians Need to Know. Current Atherosclerosis Reports 21:6.
Crossref
Crossref
P. S. Nishtala, D. Gnjidic, T. Chyou & S. N. Hilmer. (2016) Discontinuation of statins in a population of older New Zealanders with limited life expectancy. Internal Medicine Journal 46:4, pages 493-496.
Crossref
Crossref
Jean-Philippe Joseph, Mélanie Afonso, Driss Berdaï, Nathalie Salles, Antoine Bénard, Bernard Gay & Fabrice Bonnet. (2015) Bénéfices et risques des statines en prévention primaire chez la personne âgée. La Presse Médicale 44:12, pages 1219-1225.
Crossref
Crossref
Christian Constance, Ori Ben-Yehuda, Nanette K Wenger, Franklin Zieve, Jianxin Lin, Mary E Hanson, Robert S Lowe & Andrew M Tershakovec. (2014) Atorvastatin 10 mg plus ezetimibe versus titration to atorvastatin 40 mg: attainment of European and Canadian guideline lipid targets in high-risk subjects ≥65 years. Lipids in Health and Disease 13:1.
Crossref
Crossref
Cesare R. Sirtori. (2014) The pharmacology of statins. Pharmacological Research 88, pages 3-11.
Crossref
Crossref
Samer Noaman, Joseph E. Ibrahim & Robert Grenfell. (2014) Prescribing Statins for Cardiovascular Disease Prevention in the Old: An Absence of Evidence and an Absence of Guidelines. Heart, Lung and Circulation 23:7, pages 619-624.
Crossref
Crossref
Divey Manocha, Nidhi Bansal, Purva Gumaste & Sharon Brangman. (2013) Safety Profile of High-Dose Statin Therapy in Geriatric Patients with Stroke. Southern Medical Journal 106:12, pages 658-664.
Crossref
Crossref
Helle Wallach Kildemoes, Mikkel Vass, Carsten Hendriksen & Morten Andersen. (2012) Statin utilization according to indication and age: A Danish cohort study on changing prescribing and purchasing behaviour. Health Policy 108:2-3, pages 216-227.
Crossref
Crossref
Loukianos S. Rallidis, Katerina Fountoulaki & Maria Anastasiou-Nana. (2012) Managing the underestimated risk of statin-associated myopathy. International Journal of Cardiology 159:3, pages 169-176.
Crossref
Crossref
Beatriz H. Caamaño, Jairo M. González Díaz, Daniel Guerrero Bracho, Harold Herrera & Manuel Castro Samur. (2012) Brote psicótico agudo y rabdomiólisis tras el uso de lovastatina. Revista Colombiana de Psiquiatría 41:3, pages 672-679.
Crossref
Crossref
I. B. Zueva, K. I. Vanaeva & E. L. Sanez. (2012) The impact of simvastatin vs. atorvastatin on cognitive function in obese hypertensives. "Arterial’naya Gipertenziya" ("Arterial Hypertension") 18:3, pages 228-234.
Crossref
Crossref
Matthew S. Murphy & Timothy O'Brien. 2009. Pharmacology and Therapeutics. Pharmacology and Therapeutics
303
320
.
Steven K. Baker & Imtiaz A. Samjoo. (2014) A Neuromuscular Approach to Statin-Related Myotoxicity. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 35:1, pages 8-21.
Crossref
Crossref
Behzad Najafian, Donald B. Franklin & Agnes B. Fogo. (2007) Acute Renal Failure and Myalgia in a Transplant Patient. Journal of the American Society of Nephrology 18:11, pages 2870-2874.
Crossref
Crossref
C. G. P. Roberts, E. Guallar & A. Rodriguez. (2007) Efficacy and Safety of Statin Monotherapy in Older Adults: A Meta-Analysis. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 62:8, pages 879-887.
Crossref
Crossref
Joseph V. Agostini, Mary E. Tinetti, Ling Han, Gail McAvay, JoAnne M. Foody & John Concato. (2007) Effects of Statin Use on Muscle Strength, Cognition, and Depressive Symptoms in Older Adults. Journal of the American Geriatrics Society 55:3, pages 420-425.
Crossref
Crossref
Prakash DeedwaniaPeter H. StoneC. Noel Bairey MerzJuan Cosin-AguilarNevres KoylanDon LuoPamela OuyangRyszard PiotrowiczKarin Schenck-GustafssonPhilippe SellierJames H. SteinPeter L. ThompsonDan Tzivoni. (2007) Effects of Intensive Versus Moderate Lipid-Lowering Therapy on Myocardial Ischemia in Older Patients With Coronary Heart Disease. Circulation 115:6, pages 700-707.
Crossref
Crossref
Kenneth A. Antons, Craig D. Williams, Steven K. Baker & Paul S. Phillips. (2006) Clinical Perspectives of Statin-Induced Rhabdomyolysis. The American Journal of Medicine 119:5, pages 400-409.
Crossref
Crossref
Harold Bays. (2006) Statin Safety: An Overview and Assessment of the Data—2005. The American Journal of Cardiology 97:8, pages S6-S26.
Crossref
Crossref